Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma.
about
Proteomic Characterization of the World Trade Center dust-activated mdig and c-myc signaling circuit linked to multiple myelomaActive versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed?Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target.Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma.Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer.Targeting MET transcription as a therapeutic strategy in multiple myeloma.A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib.Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis.Multiple myeloma macrophages: pivotal players in the tumor microenvironment.Macrophages in multiple myeloma: emerging concepts and therapeutic implications.Targeting the tumor microenvironment: focus on angiogenesis.Cancer associated fibroblasts in hematological malignancies.Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis.The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells.Bone marrow microenvironment and the identification of new targets for myeloma therapy.Targeting the vascular endothelial growth factor pathway in the treatment of multiple myeloma.The molecular characterization and clinical management of multiple myeloma in the post-genome era.Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients.Reduction of serum IGF-I levels in patients affected with Monoclonal Gammopathies of undetermined significance or Multiple Myeloma. Comparison with bFGF, VEGF and K-ras gene mutation.Constitutive expression of IL-12R beta 2 on human multiple myeloma cells delineates a novel therapeutic target.Syndecan-1 is required for robust growth, vascularization, and metastasis of myeloma tumors in vivoImmune cells and angiogenesis.Osteoclasts are important for bone angiogenesis.The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma.Bisphosphonates as antimyeloma drugs.Biological aspects of angiogenesis in multiple myeloma.Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models.Identify multiple myeloma stem cells: Utopia?The hemopoietic stem cell niche versus the microenvironment of the multiple myeloma-tumor initiating cell.High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma.Oscillating expression of interleukin-16 in multiple myeloma is associated with proliferation, clonogenic growth, and PI3K/NFKB/MAPK activation.CXCR7 maintains osteosarcoma invasion after CXCR4 suppression in bone marrow microenvironment.Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies.Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche.Role of Endothelial Cells and Fibroblasts in Multiple Myeloma Angiogenic Switch.Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple MyelomaInduction of thymic stromal lymphopoietin in mesenchymal stem cells by interaction with myeloma cells.Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.Cytokines in Endocrine Dysfunction of Plasma Cell Disorders.Angiogenic activity of multiple myeloma endothelial cells in vivo in the chick embryo chorioallantoic membrane assay is associated to a down-regulation in the expression of endogenous endostatin
P2860
Q28393934-B7E8C104-2C24-4622-9F56-66A9DEC6C6F0Q29308099-18B8224E-F94D-4EDF-B81C-C9E7E76A2059Q30490975-237485C6-485E-41B1-B598-72381A0F8374Q33292668-0FBF7CE9-3A00-4270-B110-4E4FBF8B2D22Q33767052-778132D8-58EB-4719-B5AF-694B70BB629AQ33943962-9B7B3B1A-4FF4-409D-A1F2-662B9C54BC23Q33976734-1AAD7302-B707-4C53-B7E6-2CF269E47D5BQ34155848-D0DFB87C-965E-46E6-899A-70AF1F0DEE2DQ34329152-33C53EF5-5CAA-45A4-AA3E-7AB17D43E92CQ34329242-CFB1D6D2-64C4-4036-9B46-D6F64808B821Q35184806-60606B65-4C96-4777-A177-884D951AD139Q35550041-A6E29D04-1D45-4EFD-AEB5-1A0905B5BAD8Q35989478-4FD9DE53-A4AF-4BEF-95D8-0F4822E8243FQ36051868-9AF2FB3E-AF4C-44DC-BD9D-F99FF1603B56Q36162703-CC3FE937-F151-4818-930E-D3659C86F193Q36788503-D68DCCBC-04F1-4CA4-B4D4-19A217426AADQ36939043-83BE3E09-F07D-43EB-A9D8-410DF1F21D7EQ37046655-058A0F71-8B99-4F7E-9863-FBC6EE334AFDQ37145879-ECFA0E58-5750-40D6-820F-BFA2313E8FE3Q37351173-C76C3CB4-5B04-42F7-AD6C-C78A2FB11F2BQ37377754-9410C713-1556-4E11-AFBC-9D2EC920F5BCQ37524377-06F4CBCE-4B7C-4CED-8546-416D8C4EE22BQ37706007-977EBAD6-898E-4B29-82FD-E39C8AB18064Q37946246-D0D7F2F9-DBD0-4DA6-BAEF-40FE251E92CFQ37946695-BE62AA4B-85D1-4668-B61D-8B15E9B8FC23Q37956524-FBC80F50-3640-4FE5-9C3A-2B625C8AAED3Q38056889-352BBBC1-BB26-4C34-B03E-0CE6950C45DAQ38332486-44349E74-222A-4379-912D-8AB08AB52CDEQ38569328-C5864A25-91ED-4F80-B7DF-4A61E7FCF8E2Q38654361-4D660542-C918-47EE-B7AD-4B16CE9758A4Q38703269-AA6AF542-09B3-4BBE-BE19-599D25910A15Q38705037-53490CA5-CC80-4DCB-99C3-2CB42A334307Q38708402-3407B8A8-CC88-4529-89F3-69C536074EB3Q38932298-E65128D8-6434-4FF0-A9C0-B6BACAC2954BQ38970580-0A4D2B08-3120-4232-B3F7-4112831EE08CQ38974261-61B13E54-5487-4964-B864-000F400CA1AFQ39035696-D61F86D0-9B01-4453-AC1B-7BC6EEB19EECQ39305373-A7901424-905A-49BE-8AEA-66203997DB00Q39455586-F60340A2-519B-414D-97E4-2A7C94A27705Q39737508-F4C48BFE-20F7-4F10-8B32-2EBDD174A5E7
P2860
Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Importance of the bone marrow ...... response in multiple myeloma.
@ast
Importance of the bone marrow ...... response in multiple myeloma.
@en
type
label
Importance of the bone marrow ...... response in multiple myeloma.
@ast
Importance of the bone marrow ...... response in multiple myeloma.
@en
prefLabel
Importance of the bone marrow ...... response in multiple myeloma.
@ast
Importance of the bone marrow ...... response in multiple myeloma.
@en
P2093
P356
P1433
P1476
Importance of the bone marrow ...... response in multiple myeloma.
@en
P2093
P2888
P304
P356
10.1038/SJ.ONC.1209456
P407
P577
2006-03-06T00:00:00Z